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The Federal Drug Free Work Place Program (DFWP) has now matured to the
point of being able to return employees to sensitive testing designated positions (TDP)
after completion of treatment for their addiction. The known tendency of addicted
individuals to suffer multiple relapses prior to their final recovery has resulted in several
positive urine tests (relapses) occurring among those Federal employees who have already
completed treatment and who have been returned to TDPs. The very real potential for
further relapses occurring after additional employees return to TDPs will be a critical
factor in the ultimate success of the DFWP and in the public's impression of the
program's effectiveness.
In response to this concern, NASA has begun development of its Ongoing
Recovery Basic Information Tool (ORBIT) instrument. The aim of the NASA ORBIT
is to provide Employee Assistance Program (EAP) professionals with an advanced
clinical tool which will be helpful in supporting recovery from substance abuse and which
will allow more accurate determinations of when clients may be successfully returned to
sensitive positions.
The NASA ORBIT is a comprehensive instrument which helps identify and
quantify the client's progress in those areas which most relate to recovery and continued
abstinence. The NASA ORBIT instrument elicits detailed information from the referral
source about the employee's clinical course during treatment, involves the client in the
management of his/her own recovery, and includes the EAP professional's ongoing
clinical impression of the employee's developing strengths and remaining weaknesses.
These factors are then weighted and combined by a computer program to develop a
numerical "score" which indicates the relative degree of the client's progress and his/her
potential for continued abstinence. The NASA ORBIT "score" will provide the EAP
professional with a powerful new clinical too1 to assist in determining the advisability of
returning clients to sensitive positions. The NASA ORBIT will also provide documented
evidence to support recommendations which must be made to management concerning
the return of employees to TDPs.
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In addition, the range and thoroughness of the information elicited by the NASA
ORBIT and the requirement to observe and record details of the client's clinical course
will serve as a "prompt" for maintaining a high quality of care for these DFWP
employees. Even without quantifications of the predictability of continued successful
abstinence, we feel that the prompting function of the instrument alone will, in and of
itself, greatly improve treatment standards and facilitate the recovery process.
The NASA ORBIT instrument consists of four major components. The first is
completed by the treatment provider, and includes information about the client's medical
history, past addiction history, and progress during treatment. The second component,
completed by the EAP professional, consists of questionnaires relating to seven major
areas identified as influencing recovery, including family environment, coping skills,
vocational adjustment, personality factors, stress level, codependence, and leisure
activities. The third component of the NASA ORBIT involves the client in helping to
chart and monitor his/her own progress toward recovery. The fourth component is an
individualized recovery and back-to-work plan in cooperation with the EAP professional,
the employee, and the employee's supervisor.
The initial drafts of the NASA ORBIT instrument have been reviewed for content
and clinical appropriateness by a panel of NASA EAP professionals. Interim revised
drafts have again been reviewed and further revised. A selected group of EAP
counselors has attended a three-day intensive training course in the use of the NASA
ORBIT and are now field testing the instrument in their clinical practices.
We anticipate that twenty to thirty clients will have been assessed by the NASA
ORBIT field test over the next six months. These clients will then continue to be
followed for an additional year to determine successful abstinence. The information
collected by the field test will be analyzed and compared to evaluate and improve the
effectiveness of the items used for "scoring" the progress of clients and for predicting
successful continued abstinence.
A case-control study will also be developed to identify and evaluate the
determinants of successful abstinence among the population of Federal DFWP employees
who have already completed treatment and who have been returned to TDP positions
during the several years since the institution of the DFWP.
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Data from the field trial anddata from the case-control study will be analyzed to
prepare the weighting scheme and to develop the final NASA ORBIT scoring formula.
The revised instrument, the weighting scheme, and the scoring formula will then be Beta
tested for reliability and predictability. Following successful Beta testing, the NASA
ORBIT will be made available for use by all Federal agencies.
This instrument can also be tailored to include recover from alcohol addiction.
A later effort will incorporate data from alcohol abusers in anticipation of the addition
of alcohol testing to the DFWP. Also of interest is that we feel the core approach of the
NASA ORBIT can be modified for use in the primary prevention of addictive behavior
as well as during recovery.
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